- Home
- ALLO vs PSTL Comparison
ALLO vs PSTL Comparison
Compare ALLO & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- PSTL
- Stock Information
- Founded
- ALLO 2017
- PSTL 2018
- Country
- ALLO United States
- PSTL United States
- Employees
- ALLO N/A
- PSTL N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- PSTL Real Estate Investment Trusts
- Sector
- ALLO Health Care
- PSTL Real Estate
- Exchange
- ALLO Nasdaq
- PSTL Nasdaq
- Market Cap
- ALLO 277.8M
- PSTL 329.8M
- IPO Year
- ALLO 2018
- PSTL 2019
- Fundamental
- Price
- ALLO $1.40
- PSTL $15.05
- Analyst Decision
- ALLO Strong Buy
- PSTL Strong Buy
- Analyst Count
- ALLO 9
- PSTL 1
- Target Price
- ALLO $8.44
- PSTL $16.50
- AVG Volume (30 Days)
- ALLO 2.6M
- PSTL 172.2K
- Earning Date
- ALLO 08-06-2025
- PSTL 08-05-2025
- Dividend Yield
- ALLO N/A
- PSTL 6.47%
- EPS Growth
- ALLO N/A
- PSTL 176.54
- EPS
- ALLO N/A
- PSTL 0.28
- Revenue
- ALLO N/A
- PSTL $81,235,000.00
- Revenue This Year
- ALLO N/A
- PSTL $17.77
- Revenue Next Year
- ALLO N/A
- PSTL $10.29
- P/E Ratio
- ALLO N/A
- PSTL $53.03
- Revenue Growth
- ALLO N/A
- PSTL 23.36
- 52 Week Low
- ALLO $0.86
- PSTL $12.26
- 52 Week High
- ALLO $3.78
- PSTL $15.15
- Technical
- Relative Strength Index (RSI)
- ALLO 56.45
- PSTL 82.21
- Support Level
- ALLO $1.27
- PSTL $12.95
- Resistance Level
- ALLO $1.51
- PSTL $14.16
- Average True Range (ATR)
- ALLO 0.11
- PSTL 0.26
- MACD
- ALLO 0.04
- PSTL 0.13
- Stochastic Oscillator
- ALLO 77.55
- PSTL 100.00
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.